Circulating microRNA-21 is an early predictor of ROS-mediated damage in subjects with high risk of developing diabetes and in drug-naïve T2D

Novel insights into the regulation of miRNA transcriptional control: implications for T2D and related complications

(2018) Lucia La Sala et al.   ACTA DIABETOLOGICA

Circulating MicroRNAs in Elderly Type 2 Diabetic Patients

(2018) Giuseppina Catanzaro et al.   International Journal of Endocrinology

Cardiovascular and renal burdens of prediabetes in the USA: analysis of data from serial cross-sectional surveys, 1988–2014

(2018) Mohammed K Ali et al.   Lancet Diabetes & Endocrinology

Glucose-sensing microRNA-21 disrupts ROS homeostasis and impairs antioxidant responses in cellular glucose variability

(2018) Lucia La Sala et al.   Cardiovascular Diabetology

Ageing influences the relationship of circulating miR-33a and miR-33b levels with insulin resistance and adiposity

(2018) Fernanda-Isadora Corona-Meraz et al.   Diabetes & Vascular Disease Research

Predicting and understanding the response to short-term intensive insulin therapy in people with early type 2 diabetes

(2018) Yury O. Nunez Lopez et al.   Molecular Metabolism

Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions

(2017) Eleanor Barry et al.   BMJ-British Medical Journal

Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions

(2017) Eleanor Barry et al.   BMJ-British Medical Journal

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening

(2017) Mavis Mensah et al.   Jove-Journal of Visualized Experiments

The need for international consensus on prediabetes

(2017) Lydia E Makaroff   Lancet Diabetes & Endocrinology

A unique plasma microRNA profile defines type 2 diabetes progression

(2017) Paola de Candia et al.   PLoS One

Differential expression of microRNAs in plasma of patients with prediabetes and newly diagnosed type 2 diabetes

(2016) Shaoying Yan et al.   ACTA DIABETOLOGICA

Oscillating glucose induces microRNA-185 and impairs an efficient antioxidant response in human endothelial cells

(2016) Lucia La Sala et al.   Cardiovascular Diabetology

Extracellular microRNAs and endothelial hyperglycaemic memory: a therapeutic opportunity?

(2016) F. Prattichizzo et al.   DIABETES OBESITY & METABOLISM

Differential microRNA Profiles Predict Diabetic Nephropathy Progression in Taiwan

(2016) Hung-Yu Chien et al.   International Journal of Medical Sciences

Pancreas-enriched miRNAs are altered in the circulation of subjects with diabetes: a pilot cross-sectional study

(2016) Attila A. Seyhan et al.   Scientific Reports

Circulating miR-192 and miR-193b Are Markers of Prediabetes and Are Modulated by an Exercise Intervention

(2015) Marcelina Párrizas et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Serum MiRNA Biomarkers serve as a Fingerprint for Proliferative Diabetic Retinopathy

(2014) Shao Qing et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

2. Classification and Diagnosis of Diabetes

(2014)   DIABETES CARE

MicroRNA-146a and -21 cooperate to regulate vascular smooth muscle cell proliferation via modulation of the Notch signaling pathway

(2014) JIAN CAO et al.   Molecular Medicine Reports

A Quantitative Method to Monitor Reactive Oxygen Species Production by Electron Paramagnetic Resonance in Physiological and Pathological Conditions

(2014) Simona Mrakic-Sposta et al.   Oxidative Medicine and Cellular Longevity

Serum microRNAs as Biomarkers of Human Lymphocyte Activation in Health and Disease

(2014) Paola de Candia et al.   Frontiers in Immunology

MicroRNAs: potential mediators and biomarkers of diabetic complications

(2013) Mitsuo Kato et al.   FREE RADICAL BIOLOGY AND MEDICINE

MicroRNA-15a and MicroRNA-16 Impair Human Circulating Proangiogenic Cell Functions and Are Increased in the Proangiogenic Cells and Serum of Patients With Critical Limb Ischemia

(2012) Gaia Spinetti et al.   CIRCULATION RESEARCH

Changes in MicroRNA Expression Contribute to Pancreatic  -Cell Dysfunction in Prediabetic NOD Mice

(2012) E. Roggli et al.   DIABETES

Reactive oxygen species in cardiovascular disease

(2011) Koichi Sugamura et al.   FREE RADICAL BIOLOGY AND MEDICINE

MicroRNA-21 Orchestrates High Glucose-induced Signals to TOR Complex 1, Resulting in Renal Cell Pathology in Diabetes

(2011) Nirmalya Dey et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Oxidative Stress and Diabetic Complications

(2010) Ferdinando Giacco et al.   CIRCULATION RESEARCH

Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes

(2010) Anna Zampetaki et al.   CIRCULATION RESEARCH

MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue

(2009) Sashwati Roy et al.   CARDIOVASCULAR RESEARCH

MicroRNAs: Target Recognition and Regulatory Functions

(2009) David P. Bartel   CELL

Oscillating Glucose Is More Deleterious to Endothelial Function and Oxidative Stress Than Mean Glucose in Normal and Type 2 Diabetic Patients

(2008) A. Ceriello et al.   DIABETES

MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

(2008) Thomas Thum et al.   NATURE